Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid

Details for Australian Patent Application No. 2005204391 (hide)

Owner Lavipharm Laboratories, Inc.

Inventors Chavan, Meenal; Osborne, James

Agent Griffith Hack

Pub. Number AU-A-2005204391

PCT Pub. Number WO2005/067897

Priority 60/536,344 14.01.04 US

Filing date 14 January 2005

Wipo publication date 28 July 2005

International Classifications

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/00 (2006.01)

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/067897 Priority application(s): WO2005/067897

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005204393-Method and device for reflectance with a predetermined spectral response

2005204385-Methods for tailoring the immune response to an antigen or immunogen